TOPNWS

Wall Street slides in broad-based selloff on recession worries

Meta drops on report of EU concern over targeted ads Indexes down: Dow 0.92%, S&P 1.26%, Nasdaq 1.63% Dec 6 (Reuters) – Wall Street’s main indexes slid on Tuesday, led by declines in Meta Platforms and other technology stocks as investors worried about a longer rate-hike cycle despite warnings of a potential recession next year. …

Wall Street slides in broad-based selloff on recession worries Read More »

Wall St falls after strong service-sector data feeds hawkish Fed fears

US service sector activity picks up in November Tesla slides on reports of production cut in China Indexes down: Dow 0.70%, S&P 0.98%, Nasdaq 1.12% Dec 5 (Reuters) – Wall Street’s main indexes fell on Monday after better-than expected service-sector activity added to jitters that the US Federal Reserve might continue on its aggressive policy …

Wall St falls after strong service-sector data feeds hawkish Fed fears Read More »

Asia shares bank on eventual China opening; oil earnings

https://tmsnrt.rs/2zpUAr4 China shares push higher, dollar slips More Chinese cities ease coronavirus controls Cap on Russia oil comes into effect, impact uncertain SYDNEY, Dec 5 (Reuters) – Asian shares extended their rally on Monday as investors hoped steps to unwind pandemic restrictions in China would eventually brighten the outlook for global growth and commodity demand, …

Asia shares bank on eventual China opening; oil earnings Read More »

Canada’s deep yield curve inversion adds to BoC rate hike dilemma

TORONTO, Dec 4 (Reuters) – As the Bank of Canada considers ditching oversized interest rate hikes, it is dealing with an economy likely more overheated than previously thought but also the bond market’s clearest signal yet that recession and lower inflation lie ahead. Canada’s central bank says that the economy needs to slow from overheated …

Canada’s deep yield curve inversion adds to BoC rate hike dilemma Read More »

US FDA gives first-ever approval to fecal transplant therapy

Nov 30 (Reuters) – The US health regulator on Wednesday approved Switzerland-based Ferring Pharmaceuticals’ fecal transplant-based therapy to reduce the recurrence of a bacterial infection, making it the first therapy of its kind to be cleared in the United States. The therapy, Rebyota, targets Clostridium difficile, or C. difficile – a superbug responsible for infections …

US FDA gives first-ever approval to fecal transplant therapy Read More »

As the Fed plans to ‘raise and hold,’ new projections may show the cost

WASHINGTON, Dec 2 (Reuters) – New US Federal Reserve projections, issued later this month alongside an expected half-point interest rate increase, could show the central bank’s target rate headed toward levels last seen on the eve of the 2007 financial crisis, and will also reveal policymakers’ best guess of the fallout that will have for …

As the Fed plans to ‘raise and hold,’ new projections may show the cost Read More »

Roivant, Pfizer team up on inflammatory disease drug

Dec 1 (Reuters) – Biotech firm Roivant Sciences (ROIV.O) on Thursday launched a company with Pfizer Inc (PFE.N) focused on an experimental bowel disease treatment, as the drugmakers seek to tap into a multibillion dollar market. The drug, RVT-3101, was originally developed by Pfizer, which will hold a 25% stake in the new business, with …

Roivant, Pfizer team up on inflammatory disease drug Read More »

US FDA gives first-ever approval to fecal transplant therapy

Nov 30 (Reuters) – The US health regulator on Wednesday approved Switzerland-based Ferring Pharmaceuticals’ fecal transplant-based therapy to reduce the recurrence of a bacterial infection, making it the first therapy of its kind to be cleared in the United States. The therapy, Rebyota, targets Clostridium difficile, or C. difficile – a superbug responsible for infections …

US FDA gives first-ever approval to fecal transplant therapy Read More »